Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension (Q24194532)

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Comparative effects of two beta-blockers on cardiovascular reactivity and type A behavior in hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Dose response to chlorthalidone in patients with mild hypertension; Efficacy of a lower dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Isolated systolic hypertension in the elderly. A placebo-controlled, dose-response evaluation of chlorthalidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Diuretics, Serum and Intracellular Electrolyte Levels, and Ventricular Arrhythmias in Hypertensive Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Glucose and insulin levels during diuretic therapy in hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Atenolol and chlorthalidone in combination for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Effectiveness of Antihypertensive Medications in Office and Ambulatory Settings: A Placebo-Controlled Comparison of Atenolol, Metoprolol, Chlorthalidone, Verapamil, and an Atenolol-Chlorthalidone Combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Practolol and bendrofluazide in treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Clonidine and guanfacine in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Ticrynafen and hydrochlorothiazide in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Antihypertensive effects of low doses of hydrochlorothiazide in hypertensive black Zimbabweans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Treatment of benign essential hypertension: comparison of furosemide and hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Once daily treatment of mild to moderate hypertension with xipamid: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Cardiovascular protective properties of indapamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

How do thiazide and thiazide-like diuretics lower blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Chlorthalidone: don't call it "thiazide-like" anymore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Blood pressure lowering efficacy of renin inhibitors for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Pharmacotherapy for hypertension in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Blood pressure lowering efficacy of loop diuretics for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

First-line drugs for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Clinical positioning of indapamide sustained release 1.5mg in management protocols for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Efficacy and reduced metabolic side effects of a 15-mg chlorthalidone formulation in the treatment of mild hypertension. A multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Metabolic and hypotensive effects of ethacrynic acid. Comparative study with hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Chlorthalidone in mild hypertension - dose response relationship

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Pharmacokinetic studies with chlorthalidone (hygroton�) in man

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Factorial Antihypertensive Study of an Extended-Release Metoprolol and Hydrochlorothiazide Combination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

The effects of spironolactone and chlorthalidone on arterial pressure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Ace inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Low dose bendrofluazide (1.25 mg) effectively lowers blood pressure over 24 h: results of a randomized, double-blind, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Antihypertensive action of bendroflumethiazide: increased prostacyclin production?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Duration of antihypertensive effect of a single daily dose of hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Unnecessary diuretic therapy in the elderly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. Systolic Hypertension in the Elderly Program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

The effects of thiazide diuretics upon plasma lipoproteins.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Evaluation of Indapamide in the Treatment of Hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

The combination of chlorthalidone with nifedipine does not exert an additive antihypertensive effect in essential hypertensives: a crossover multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Moxonidine and hydrochlorothiazide in combination: a synergistic antihypertensive effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

The Antihypertensive Properties of the Angiotensin-Converting Enzyme Inhibitor Moexipril Given Alone or in Combination with a Low Dose of a Diuretic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Ambulatory blood pressure profiles in patients treated with once-daily diltiazem extended-release or indapamide alone or in combination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Systolic hypertension in the elderly program (SHEP). The first three months

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Cilazapril plus hydrochlorothiazide: improved efficacy without reduced safety in mild to moderate hypertension. A double-blind placebo-controlled multicenter study of factorial design

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Antihypertensive Activity of a New Agent, Indapamide: A Double-Blind Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Prospective study on the treatment of mild hypertension in the aged

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Long-acting and short-acting diuretics in mild essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Conclusions and implications of the systolic hypertension in the elderly program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Comparison of the clinical usefulness of diuretics in elderly and younger essential hypertension--double blind trial using tripamide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021

Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003824.PUB2

7 January 2021